Generating some money is clearly better than generating none, yes. Most R&D companies make $0 and simply burn cash until they get approvals, acquired, or go under. Elite can offset some of its R&D costs with the generic side of the business which removes risk.
I don’t think anyone is here solely because of the small generic products they are currently selling.
Market Data 
Markets 
AI
